跳至主要内容
临床试验/EUCTR2004-004003-38-HU
EUCTR2004-004003-38-HU进行中(未招募)不适用

Kettos vak, randomizalt komparativ vizsgalat a Gynevac lactobacillus vakcinaval vegzett kezeles hatekonysaganak es biztonsaganak osszehasonlitasara a hagyomanyos antibiotikus (ofloxacin) kezelessel chronikus prostatitsben szenvedo betegek koreben - GYNEVAC/PROSTATIS

Vakcina Kft0 个研究点目标入组 100 人开始时间: 2004年11月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Vakcina Kft
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Male patients of 25 to 75 years of age
  • Symptoms of chronic prostatitis have been present fort a period not less than 6 months
  • Positive result of the University of Washington Symptom Score (UWSS) (not less than 10 score values when answered the first 14 questions of the test)
  • The patient is expected to collaborate and has signed the written informed consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Carcinoma of the prostate gland
  • Relative contraindications to the use Gynevac lactobacillus vaccine (acute infections, immune deficiency states, etc)
  • Hypersensitivity to ofloxacin or to the ingredients of Gynevac lactobacillus vaccine (formaldehyde, thiomersal)
  • Drug dependence, alcoholism

研究者

发起方
Vakcina Kft

相似试验